Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Integer HoldingsFRA:WGB 82 EBITDA Margin % is 14.29% as of Jun. 2026, which is 20% below its 10-year median of 17.82. GuruFocus rates FRA:WGB with a GF Score™ of 82/100 and a GF Value™ of €104.37 (Fairly Valued). The stock has 6 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Integer Holdings ranks better than 69.12% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Integer Holdings's EBITDA for the
three
months ended in Jun. 2026 was €58 Mil. Integer Holdings's Revenue for the
three
months ended in Jun. 2026 was €403 Mil. Therefore, Integer Holdings's EBITDA margin for the quarter that ended in Jun. 2026 was 14.29%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Integer Holdings EBITDA Margin % Related Terms
Integer Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Integer Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:WGB vs HAE, IRTC, ESTA: EBITDA Margin % Comparison
For the Medical Devices subindustry, Integer Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integer Holdings EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Integer Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integer Holdings (FRA:WGB) has a EBITDA Margin % of 14.29% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Integer Holdings and its competitors. This is 20% below median its historical median of 17.82. Over the past decade, Integer Holdings' EBITDA Margin % has ranged from 14.87 to 20.53. According to the industry distribution chart, Integer Holdings ranks #252 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 30.9%.
Is Integer Holdings' EBITDA Margin % too high?
Integer Holdings' current EBITDA Margin % of 14.29% is 20% below median its 10-year median of 17.82. Over the past 10 years, this metric has ranged from a low of 14.87 to a high of 20.53. The Medical Devices & Instruments industry median EBITDA Margin % is 7.59. Integer Holdings' value of 14.29% is 88.3% above this industry median. Based on the distribution chart, Integer Holdings ranks #252 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Integer Holdings has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Integer Holdings' EBITDA Margin % compare to HAE and IRTC?
According to the Medical Devices & Instruments industry distribution chart, Integer Holdings ranks #252 out of 816 companies for EBITDA Margin %. This puts Integer Holdings in the upper half of its industry. The industry median EBITDA Margin % is 7.59. Integer Holdings' value of 14.29% is 88.3% above this benchmark. Historically, Integer Holdings' own EBITDA Margin % has ranged from 14.87 to 20.53 over the past decade. While the company's 10-year median is 17.82 vs. the industry median of 7.59, Integer Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.59, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integer Holdings's current EBITDA Margin % of 14.29% is 88.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Integer Holdings and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integer Holdings's current EBITDA Margin % is 14.29%, which is 20% below median its own 10-year median of 17.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integer Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integer Holdings (FRA:WGB) is currently considered Fairly Valued. The stock's GF Value™ is €104.37, compared to a current price of €107.00 — trading 2.5% above its estimated fair value. The current EBITDA Margin % is 14.29%, which is 20% below median its 10-year median of 17.82 and 88.3% above the Medical Devices & Instruments industry median of 7.59. Integer Holdings' overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Integer Holdings (FRA:WGB), the current EBITDA Margin % is 14.29% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integer Holdings (FRA:WGB) Overvalued in 2026?
Based on GuruFocus' analysis, Integer Holdings stock appears to be overvalued.
The current stock price of €107.00 is trading 2.5% above its estimated GF Value™ of €104.37.
GuruFocus considers Integer Holdings to be Fairly Valued.
Key valuation signals for FRA:WGB:
EBITDA Margin %: 14.29% (20% below median its 10-year median of 17.82)
GF Value™: €104.37 vs. price of €107.00 (2.5% above fair value)
Industry Position: 88.3% above the Medical Devices & Instruments median (#252 of 816)
No single metric tells the full story. See the FRA:WGB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
82GF Score
Get the complete analysis for FRA:WGB
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:WGB has been successfully added to your 
